Table 1.
Parameter | Non-Liver metastases N= 259 (means ± SEM) or (%) | Liver metastases N= 97 (means ± SEM) or (%) |
---|---|---|
Age | 58.38 ± 0.79 | 56.93 ± 1.17 |
FR-CTC | 10.26 ± 0.12 **** | 13.38 ± 0.35 **** |
HSP90 | 51.16 ± 2.87 **** | 78.19 ± 6.10 **** |
CEA | 39.79 ± 9.69 * | 84.59 ± 26.70 * |
CA199 | 41.09 ± 9.55 *** | 126.10 ± 28.33 *** |
KI67 | 69.81 ± 0.85 | 72.90 ± 1.39 |
P53 | 55.86 ± 1.16 | 52.21 ± 2.45 |
Tumor diameter | 4.37 ± 0.11 | 4.80 ± 0.19 |
Number of lymph node metastases | 1 ± 0.16 **** | 3± 0.42**** |
Gender | ||
Male | 104 (40.15) | 58 (59.79) |
Female | 155 (59.85) | 39 (40.21) |
CK7 | ||
Positive | 15 (5.79) | 8 (8.25) |
Negative | 244 (94.21) | 89 (91.75) |
CK20 | ||
Positive | 86 (33.20) | 28 (28.87) |
Negative | 173 (66.80) | 69 (71.13) |
Villin | ||
Positive | 70 (27.03) | 27 (27.84) |
Negative | 189 (72.97) | 70 (72.16) |
β-catenin | ||
Positive | 63 (24.32) | 14 (14.43) |
Negative | 196 (75.68) | 83 (85.57) |
S100 | ||
Positive | 55 (21.24) | 16 (16.50) |
Negative | 204 (78.76) | 81 (83.50) |
Location of primary tumor | ||
Colon | 123(47.49) | 56 (57.73) |
Rectal | 136 (52.51) | 41 (42.27) |
Differentiation type | ||
Well differentiation | 18 (6.95) | 3 (3.09) |
Moderately differentiation | 233(89.96) | 88 (90.72) |
Poorly differentiation | 8 (3.09) | 6 (6.19) |
*p > 0.05 between liver metastases and non-liver metastases.
***p > 0.001 between liver metastases and non-liver metastases.
****p > 0.0001 between liver metastases and non-liver metastases.